Aptatargets
Madrid, ES · 2 known investors
Find your way into Aptatargets
24 people in our graph share verified history with the Aptatargets team — schools, employers, funds. One of them is your warm intro.
Antonio Herceunlockedknows Maria Eugenia · together at Aptatargets (overlapped)
×10knows the team · via Universidad CEU San Pablo
knows the team · via Aptatargets
aptaTargets develops aptamer-based therapeutics and diagnostics for cerebrovascular diseases, with a lead program (ApTOLL) targeting stroke treatment. The company applies aptamer technology platforms to clinical applications in neurology.
Founders & leadership
D
DavidCo-Founder & CEO
ME

Maria EugeniainCo-Founder & CFOMaria Eugenia is co-founder and CFO of aptaTargets, where she leads finance, corporate development, and strategic guidance for the aptamer-based therapeutics company. She has nearly two decades of experience in life sciences entrepreneurship, has directed over €20 million in public and private funding rounds, and is a co-inventor on multiple international patents related to the company's therapeutic programs.
Investors · 2
Frequently asked questions
- What does Aptatargets do?
- aptaTargets develops aptamer-based therapeutics and diagnostics for cerebrovascular diseases, with a lead program (ApTOLL) targeting stroke treatment. The company applies aptamer technology platforms to clinical applications in neurology.
- Who founded Aptatargets?
- Aptatargets was founded by David, Maria Eugenia.
- Who are Aptatargets's investors?
- Aptatargets's investors include Criteria Bio Ventures, Inveready Technology Investment Group.
- Where is Aptatargets headquartered?
- Aptatargets is headquartered in Madrid, ES.


